At 20n, we are building the biotech of the future, one that puts software at the center of the genetic design process. In an age where software startups can get to worldwide scale with a few engineers, we ask if biotech can do the same? With the advent of labs-in-the-cloud, contract research and manufacturing (CROs and CMOs), the answer is increasingly YES. We let the software discover, design and invent new genetic constructs, and hook it up to lab-in-the-clouds to test and validate. We build and test 5-10 new inventions every week, and assimilate terabytes of measurement data in the process. 20n is creating the largest (and ever-growing) data source of functionally accurate biochemical data.
20n total Funding
20n latest funding size
Time since last funding
|3 years ago|
|Khosla Ventures, Great Oaks Venture Capital, Blumberg Capital, Y Combinator|
20n has 186 number of Twitter Followers. The number of followers has grown 1.1% quarter over quarter